- Jakarta hospital has installed the world's most advanced radiosurgery system for treatment of brain cancer, and other brain disorders

JAKARTA, Indonesia, Feb. 22, 2013 (ANTARA/PRNewswire) -- In conjunction with the inauguration of the Gamma Knife® Center Indonesia, Siloam International Hospitals Lippo Karawaci will host a symposium on February 23 entitled "Gamma Knife - the Knifeless Brain Surgery for Indonesia." The program will feature leading clinicians from Indonesia and United States who will discuss the benefits of Leksell Gamma Knife® Perfexion™, a stereotactic radiosurgery system specifically designed to treat one or more brain and head tumors in a single session. The facility will be inaugurated by Dr. Mochtar Riady, founder of the Lippo Group of companies.

Featured speakers in the Symposium include:

• Professor Eka Wahjoepramono, Dean of Faculty of Medicine, University of Pelita Harapan
• Professor Susworo, Radiation Oncologist, Siloam Hospitals
• Dr. Alvaro Martinez, Radiation Oncologist, Michigan Healthcare Professionals
• Dr. Fernando Diaz, Neurosurgeon, Beaumont Health Systems

"By offering radiosurgery treatment with Leksell Gamma Knife, we are affirming Siloam's commitment to providing the very best health care available to the Indonesian community," says Professor Dr. Eka J Wahjoepramono, Neurosurgeon, Siloam Hospitals, and Dean of Faculty of Medicine at Universitas Pelita Harapan.

Gamma Knife radiosurgery is a gentler alternative to traditional brain surgery for illnesses such as metastatic disease, which is cancer that has travelled to the brain from elsewhere in the body. With pinpoint accuracy, the system delivers up to thousands of low-intensity radiation beams to one or more targets in a single session. Leksell Gamma Knife Perfexion installed at the Gamma Knife Center Indonesia is the first of its kind in Southeast Asia.

Today, Gamma Knife surgery is performed in hundreds of leading hospitals and clinics around the world. Around 65,000 patients undergo Gamma Knife surgery every year, and this unique procedure has an impressive scientific track record with thousands of peer-reviewed articles. To learn more, visit www.elekta.com/gammaknife.

For further information, please contact:
Johan Andersson Melbi, Director, Investor Relations, Elekta AB
Tel: +46 702 100 451, email: johan.anderssonmelbi@elekta.com
Time zone: CET: Central European Time

Michelle Joiner, Director, Global Public Relations and Brand Management, Elekta
Tel: +1 770-670-2447, email: michelle.joiner@elekta.com
Time zone: ET: Eastern Time

About Elekta
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives.

Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,400 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. Website: www.elekta.com.

Editor: PR Wire
Copyright © ANTARA 2013